The opportunity is either (1) a pharmaceutical in development that has reached proof of concept in humans, or (2) is a pharmaceutical product currently in the market and you would like to explore potential joint regional commercialization efforts, or (3) is a diagnostic in late stage development connected with drug treatment or in the area of oncology »